Netscientific Share Discussion Threads

[ridingthewaves1] 14/11/2022 12:48

Moving slowly

[kingston78] 14/11/2022 12:46

Thank you for sharing the above excellent news from PDS. I would not be surprised if a giant pharmaceutical company decide to takeover PDS within two years at significant premium to its current share price.

[ridingthewaves1] 14/11/2022 12:44

The herd are not in yet

[blakieboy7] 10/11/2022 08:07

The last Proaxis update was 6 months ago - Registration of the assay for a CE Mark has been formally submitted. How long does this step take?!

[loafofbread] 08/11/2022 19:38

Our holding in PDSB is now worth exactly half our market cap.

[btgman] 07/11/2022 16:21

Totally agree Loaf. Anyone selling must be frightened of making money.

AIMHO
GLA
BTG

[blakieboy7] 07/11/2022 15:43

Glad to see NSCI release this RNS today

[blakieboy7] 07/11/2022 13:53

Agreed. Amazing results today

[loafofbread] 07/11/2022 13:47

Enough data to now start signing up some partnerships.

Unless they get taken out first for my $20!

NSCI shareholders asleep at the wheel again!

[loafofbread] 07/11/2022 13:25

Great results out from PDSB.

More data proving up the value of the platform.

No doubt the NSCI RNS will pull in a few buyers.

[blakieboy7] 07/11/2022 07:59

About 2 years worth of data coming out 8am ET Monday morning From PDS0101/chemo combo for cervical cancer

[blakieboy7] 07/11/2022 07:23

Hopefully very positive news from across the pond from 1pm today reF PDSB

[loafofbread] 06/11/2022 20:58

At a CAGR of 18.1% Liquid Biopsy Market size is Expected to Gain $5.8 billion by 2026

Nice to see Vortex listed!


The major players operating in this market are F. Hoffmann-La Roche Ltd. (Switzerland), Myriad Genetics, Inc. (US), QIAGEN N.V. (Netherlands), Thermo Fisher Scientific, Inc. (US), Guardant Health, Inc. (US), MDxHealth SA (Belgium), Exact Sciences Corporation (US), Illumina Inc. (US), Sysmex Inostics (US), Bio-Rad Laboratories, Inc. (US), Biocept, Inc. (US), NeoGenomics, Inc. (US), ANGLE plc (UK), Menarini-Silicon Biosystems (Italy), Vortex Biosciences, Inc. (US), Exosome Diagnostics, Inc. (US), Agena Bioscience, Inc. (US), MedGenome Inc. (US), Epigenomics AG (Germany), and Personal Genome Diagnostics, Inc. (US).

[blakieboy7] 01/11/2022 14:38

PDSB up over 5% so far

[blakieboy7] 26/10/2022 11:47

I think that's just a matter of time Kingston

[kingston78] 26/10/2022 11:07

Yesterday the share price of PDSB was 5.42 USD▲ +0.51 (+10.39%). It must be worth more than before to NSCI, as the US$ is stronger. Chart wise, PDSB is bullish because it has broken the 200-day EMA for the first time this year.

NSCI is not solely reliant on the performance of PDSB but every little helps.

I am hoping for a ground-breaking news from NSCI on one of its portfolio companies that will value more than NSCI itself.

[robward] 25/10/2022 19:26

https://twitter.com/LiySav/status/1584964823804018690?t=JQdKxZnK96Zo6OIv5gRCDQ&s=19

[t182 bull] 25/10/2022 19:21

Ain't no way Frank sells for $20, atleast he better not, I'm hoping for $30, at the absolute minimum

[blakieboy7] 25/10/2022 19:19

PDSB up over 11% now, it's a good day

[loafofbread] 25/10/2022 18:55

Can't wait to wake up one day and find PDSB has gone for $20 or $600M.

Even more fun will be how long it takes for investors over here to realise we are worth £1.40 just on PDSB cash and everything else is in for free!

[blakieboy7] 25/10/2022 16:18

PDSB up another 5% so far

[blakieboy7] 24/10/2022 20:22

The market will wake up to this soon enough!!

[kingston78] 24/10/2022 18:48

The consensus 1 year target price for PDSB is $16 (lower than the previous US$20) compared with a current price of US$ 4.79, so there is plenty of upside. Similarly, NSCI may rise to the £2 level. I anticipate good news flow from any one of its investee companies. The child will be bigger than the parent; that's how I see NSCI.